EyePoint to Share DURAVYU Clinical Trial Updates at TD Cowen Healthcare Conference

EyePoint to Share DURAVYU Clinical Trial Updates at TD Cowen Healthcare Conference

EyePoint Pharmaceuticals (NASDAQ: EYPT) announced that its President and CEO, Jay S. Duker,…

Continue Reading